FRESH TRACKS THERAPEUTICS IN (FRTX)

US10802T2042 - Common Stock

0.97  0 (0%)

After market: 0.9522 -0.02 (-1.84%)

FRESH TRACKS THERAPEUTICS IN

NASDAQ:FRTX (9/28/2023, 7:00:00 PM)

After market: 0.9522 -0.02 (-1.84%)

0.97

0 (0%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)08-10 2023-08-10/amc
Earnings (Next)11-08 2023-11-08/amc
Ins OwnersN/A
Inst Owners2.78%
Market Cap5.73M
Shares5.91M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts82.86
IPO03-10 1993-03-10
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

FRTX Daily chart

Company Profile

Fresh Tracks Therapeutics, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. The company is headquartered in Boulder, Colorado and currently employs 13 full-time employees. The firm is engaged in transforming patient lives through the development of differentiated prescription therapeutics. Its pipeline is focused on providing existing treatment paradigms and features several new chemical entities that inhibit novel targets with potential for autoimmune, inflammatory, and other debilitating diseases. The Company’s strategy is exploring therapies by identifying, pursuing, and developing therapeutics that can help people struggling with autoimmune, inflammatory, and other debilitating diseases. Its pipeline includes FRTX-02, FRTX-10, Next-Generation Kinase Inhibitors and FRTX-03. FRTX-02 is a potential Oral DYRK1A Inhibitor for the treatment of autoimmune and inflammatory diseases. Its FRTX-10 is a covalent Stimulator of Interferon Genes (STING) inhibitor candidate for the potential treatment of autoimmune, inflammatory, and rare genetic diseases.

Company Info

FRESH TRACKS THERAPEUTICS IN

5777 Central Ave Ste 102

Boulder COLORADO

P: 17205054755.0

Employees: 13

Website: https://www.frtx.com/

FRTX News

News Image9 days ago - ChartmillKeep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

News Image9 days ago - ChartmillUnusual volume stocks are being observed in Wednesday's session.

Let's explore the current happenings on the US markets on Wednesday. Below, you'll find the stocks exhibiting unusual volume in today's session.

News Image9 days ago - ChartmillThese stocks are moving in today's session

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.

News Image9 days ago - ChartmillWhich stocks are gapping on Wednesday?

Today's session on Wednesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

News Image9 days ago - ChartmillGet insights into the top gainers and losers of Wednesday's pre-market session.

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

News Image9 days ago - Seeking AlphaFresh Track Therapeutics board approves plan to liquidate company (FRTX)

Fresh Tracks Therapeutics (FRTX) said that its board has approved a plan to dissolve and liquidate the company, subject to shareholder approval. Read more here.

FRTX Twits

Here you can normally see the latest stock twits on FRTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example